Platform Technologies and the Collaboration Paradox
Executive Summary
For all the innovations they promise in a drug industry with me-too products, the fact remains that contemporary drug discovery technologies increase the time required to produce a new drug. In genomics, companies now pursue their own targets, looking to create as much intellectual property around them as possible. They thereby keep their competitors away from the field--but they also lose their help.
You may also be interested in...
Global ‘Fair Access’ Coronavirus Vaccine Fund Launched, AZ Doubles Output Target
Pharma is looking to GAVI to oversee a fair distribution and avoid ‘vaccine nationalism’ – but countries can still sign bilateral deals with companies.
FDA Details Alternatives For COVID-19 Test Supplies
The US agency has released a document explaining what COVID-19 testing supplies may be substituted.
Curecumin Piques US Consumers’ Interest; UK Curiosity Grows For Omega-3, Survey Shows
Marketing consultant Buzzback surveyed 800 consumers in March, prior to novel coronavirus shutdowns in the two countries, to identify ingredients that offer opportunities for brands in health care, wellness and skin care.
Need a specific report? 1000+ reports available
Buy Reports